362 related articles for article (PubMed ID: 34684168)
21. Genetic-guided Risk Assessment and Management of Thyroid Cancer.
Xing M
Endocrinol Metab Clin North Am; 2019 Mar; 48(1):109-124. PubMed ID: 30717896
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic and prognostic value of cell-cycle regulatory genes in malignant thyroid neoplasms.
Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
World J Surg; 2006 May; 30(5):767-74. PubMed ID: 16547620
[TBL] [Abstract][Full Text] [Related]
23. Mutational status may supersede tumor size in predicting the presence of aggressive pathologic features in well differentiated thyroid cancer.
Semsar-Kazerooni K; Morand GB; Payne AE; da Silva SD; Forest VI; Hier MP; Pusztaszeri MP; Tamilia M; Payne RJ
J Otolaryngol Head Neck Surg; 2022 Mar; 51(1):9. PubMed ID: 35246262
[TBL] [Abstract][Full Text] [Related]
24. Mutation profiles of follicular thyroid tumors by targeted sequencing.
Duan H; Liu X; Ren X; Zhang H; Wu H; Liang Z
Diagn Pathol; 2019 May; 14(1):39. PubMed ID: 31077238
[TBL] [Abstract][Full Text] [Related]
25. The prognostic significance of CXCR4 and SDF-1 in differentiated thyroid cancer depends on CD8+ density.
Wilhelm A; Lemmenmeier I; Lalos A; Posabella A; Kancherla V; Piscuoglio S; Delko T; von Flüe M; Glatz K; Droeser RA
BMC Endocr Disord; 2022 Nov; 22(1):292. PubMed ID: 36419107
[TBL] [Abstract][Full Text] [Related]
26. DICER1 Mutations Do Not Always Indicate Dismal Prognosis in Pediatric Poorly Differentiated Thyroid Carcinomas.
Yegen G; Altay AY; Yılmaz İ; İşcan Y; Sormaz İC; Aksakal N; Önder S; Mete Ö
Endocr Pathol; 2023 Sep; 34(3):279-286. PubMed ID: 37574466
[TBL] [Abstract][Full Text] [Related]
27. Well differentiated follicular thyroid neoplasia: impact of molecular and technological advances on detection, monitoring and treatment.
Gianoukakis AG; Giannelli SM; Salameh WA; McPhaul LW
Mol Cell Endocrinol; 2011 Jan; 332(1-2):9-20. PubMed ID: 21094678
[TBL] [Abstract][Full Text] [Related]
28. [Biological markers in thyroid tumors].
Matsuo SE; Martins L; Leoni SG; Hajjar D; Ricarte-Filho JC; Ebina KN; Kimura ET
Arq Bras Endocrinol Metabol; 2004 Feb; 48(1):114-25. PubMed ID: 15611824
[TBL] [Abstract][Full Text] [Related]
29. DNA methylation profiling of well-differentiated thyroid cancer uncovers markers of recurrence free survival.
Mancikova V; Buj R; Castelblanco E; Inglada-Pérez L; Diez A; de Cubas AA; Curras-Freixes M; Maravall FX; Mauricio D; Matias-Guiu X; Puig-Domingo M; Capel I; Bella MR; Lerma E; Castella E; Reverter JL; Peinado MÁ; Jorda M; Robledo M
Int J Cancer; 2014 Aug; 135(3):598-610. PubMed ID: 24382797
[TBL] [Abstract][Full Text] [Related]
30. Molecular Markers Involved in Tumorigenesis of Thyroid Carcinoma: Focus on Aggressive Histotypes.
Penna GC; Vaisman F; Vaisman M; Sobrinho-Simões M; Soares P
Cytogenet Genome Res; 2016; 150(3-4):194-207. PubMed ID: 28231576
[TBL] [Abstract][Full Text] [Related]
31. Risk Stratification Using a Novel Genetic Classifier Including
Jung CK; Jung SH; Jeon S; Jeong YM; Kim Y; Lee S; Bae JS; Chung YJ
Thyroid; 2020 Nov; 30(11):1589-1600. PubMed ID: 32326836
[No Abstract] [Full Text] [Related]
32. Integrated Analysis of Thyroid Cancer Public Datasets Reveals Role of Post-Transcriptional Regulation on Tumor Progression by Targeting of Immune System Mediators.
Geraldo MV; Kimura ET
PLoS One; 2015; 10(11):e0141726. PubMed ID: 26536459
[TBL] [Abstract][Full Text] [Related]
33. Long Non-Coding RNA ZFAS1 as a Novel Potential Biomarker for Predicting the Prognosis of Thyroid Cancer.
Han CG; Huang Y; Qin L
Med Sci Monit; 2019 Apr; 25():2984-2992. PubMed ID: 31012438
[TBL] [Abstract][Full Text] [Related]
34. The predictive value of circular RNAs in the diagnosis, prognosis and clinicopathological features of thyroid cancer: A systematic review and meta-analysis.
Zhu C; Feng Z; Hong F; Sun H; Wang Z; Zhao Z; Zhang F
Pathol Res Pract; 2022 Aug; 236():153871. PubMed ID: 35797852
[TBL] [Abstract][Full Text] [Related]
35. Tumor-Infiltrating T Cells and the PD-1 Checkpoint Pathway in Advanced Differentiated and Anaplastic Thyroid Cancer.
Bastman JJ; Serracino HS; Zhu Y; Koenig MR; Mateescu V; Sams SB; Davies KD; Raeburn CD; McIntyre RC; Haugen BR; French JD
J Clin Endocrinol Metab; 2016 Jul; 101(7):2863-73. PubMed ID: 27045886
[TBL] [Abstract][Full Text] [Related]
36. A Narrative Review of Genetic Alterations in Primary Thyroid Epithelial Cancer.
Romei C; Elisei R
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572167
[TBL] [Abstract][Full Text] [Related]
37. Cancer stem-like cells and thyroid cancer.
Guo Z; Hardin H; Lloyd RV
Endocr Relat Cancer; 2014 Oct; 21(5):T285-300. PubMed ID: 24788702
[TBL] [Abstract][Full Text] [Related]
38. Identification of Key Genes in Thyroid Cancer Microenvironment.
Zhao K; Yang H; Kang H; Wu A
Med Sci Monit; 2019 Dec; 25():9602-9608. PubMed ID: 31839674
[TBL] [Abstract][Full Text] [Related]
39. Loss of estrogen receptor Beta expression in follicular thyroid carcinoma predicts poor outcome.
Heikkilä A; Hagström J; Mäenpää H; Louhimo J; Siironen P; Heiskanen I; Haglund C; Arola J
Thyroid; 2013 Apr; 23(4):456-65. PubMed ID: 23106428
[TBL] [Abstract][Full Text] [Related]
40. Primary high-grade non-anaplastic thyroid carcinoma: a retrospective study of 364 cases.
Xu B; David J; Dogan S; Landa I; Katabi N; Saliba M; Khimraj A; Sherman EJ; Tuttle RM; Tallini G; Ganly I; Fagin JA; Ghossein RA
Histopathology; 2022 Jan; 80(2):322-337. PubMed ID: 34449926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]